Catalyst Pharmaceutical Partners, Inc. Announces Presentation to be Made at the American Epilepsy Society's 65th Annual Meeting

CORAL GABLES, Fla., Dec. 2, 2011 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX - News) today announced that a poster presentation demonstrating that CPP-115, Catalyst's next-generation GABA aminotransferase inhibitor, suppresses infantile spasms (IS) in the rat multiple-hit model will be made on December 3, 2011 at the American Epilepsy Society's 65th Annual Meeting (AES) to be held December 2-6, 2011 at the Baltimore Convention Center in Baltimore, Maryland.